1.
Garvey WT, Birkenfeld A, Dicker D, Mingrone G, Pedersen S, Satylganova A, et al. EFFICACY AND SAFETY OF LIRAGLUTIDE 3.0 mg IN INDIVIDUALS WITH OVERWEIGHT OR OBESITY AND TYPE 2 DIABETES (T2D) TREATED WITH BASAL INSULIN: THE SCALE INSULIN TRIAL. J ASEAN Fed Endocr Soc [Internet]. 2022 May 4 [cited 2024 Nov. 23];34(2):12. Available from: https://asean-endocrinejournal.org/index.php/JAFES/article/view/1859